The Effect of Cysteine, Tryptophan and Tyrosine Supplements on Breast Milk

Inclusion Criteria: * Subjects would be healthy mothers who are breastfeeding at the moment, but plan to stop at the time of study * The subject, as reported, should be in a good health * The subject is not taking any medication * The subject is not taking any investigational medicinal product within 8 weeks prior to dosing * The subject does not have any known hypersensitivity to components in the proposed treatment * The subject does not have a history of severe drug allergy or drug hypersensitivity Other general medical requirements for inclusion: * Age 18 to 45 * BMI 19 to 40 (kg/m2) * Resting pulse between 45 and 100 bpm * Systolic blood pressure between 91 and 139 mmHg (inclusive) * Diastolic blood pressure between 51 and 90 mmHg (inclusive) * Orthostatic blood pressure change \<20 mmHg (based on the difference between supine and standing (1 minute) systolic blood pressure) * The subject is in good health based on their report and answer to general health questionnaire Exclusion Criteria: * The subject has taken any investigational medicinal product within 8 weeks prior to dosing * The subject is pregnant (based upon urine pregnancy test at time of screening and day of supplement intake) * The subject has known hypersensitivity to components in the proposed treatment or to related compounds * The subject has a history of severe drug allergy or drug hypersensitivity involving an anaphylactic reaction i.e. shortness of breath and/or reduced blood pressure * Subjects who are smoking more than one package of cigarette per day will be excluded from the study * The subject decides to breastfeed the infant on the study day